Collection of Anonymized Samples
1 other identifier
observational
1,500
1 country
1
Brief Summary
This is a generic sample collection study for collecting blood, stool, rectal swabs, nasal washes, nasopharyngeal aspirates, nasopharyngeal swabs, throat swabs, nasal swabs, and urine from human sources. Subjects will be recruited from BioFire Diagnostics employees and from the general community. Subjects may be asked about recent or ongoing illness at the time of specimen collection and these symptoms will be recorded and attached to the sample. No other identifying information will be collected and the samples will be kept anonymous.The samples may be used internally or by external sites, such as the clinical study sites, for evaluating and determining performance characteristics of in vitro diagnostic devices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 9, 2017
CompletedFirst Submitted
Initial submission to the registry
October 18, 2017
CompletedFirst Posted
Study publicly available on registry
October 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2027
October 24, 2017
October 1, 2017
10 years
October 18, 2017
October 23, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
PCR Amplification Curves
PCR amplification curves will be used to confirm the presence or absence of target analytes.
10 years
Eligibility Criteria
Employees of BioFire Diagnostics, and the general community of the greater Salt Lake City area.
You may qualify if:
- Consenting adult
You may not qualify if:
- Weigh less that 110 lb for blood collection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
BioFire Diagnostics
Salt Lake City, Utah, 84103, United States
Biospecimen
Blood, stool, rectal swabs, nasal washes, nasopharyngeal aspirates, nasopharyngeal swabs, throat swabs, nasal swabs, and urine from human sources.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 18, 2017
First Posted
October 24, 2017
Study Start
October 9, 2017
Primary Completion (Estimated)
October 1, 2027
Study Completion (Estimated)
October 1, 2027
Last Updated
October 24, 2017
Record last verified: 2017-10